MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.45 -0.11 (-0.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Debt Ratio (2020 - 2022)

Updated

MoonLake Immunotherapeutics' Debt Ratio came in at 0.00 for Q1 2022, down 100.0% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Debt Ratio (2020 - 2022) Analysis & Trends

For FY2021, MoonLake Immunotherapeutics' Debt Ratio was 1.55.

  • Going back by year, Debt Ratio was 0.00 in FY2020.
  • The Q1 2022 figure represents the lowest quarterly Debt Ratio since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 MoonLake Immunotherapeutics 983.83 Mn -685.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 0.00
Dec 31, 2021 1.55
Dec 31, 2020 0.00
API Access

MoonLake Immunotherapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MLTX&period=max&api_key=YOUR_API_KEY